nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—PTGS1—malignant glioma	0.477	0.636	CbGaD
Flurbiprofen—PTGS2—malignant glioma	0.273	0.364	CbGaD
Flurbiprofen—Fibrosis—Carmustine—malignant glioma	0.00495	0.037	CcSEcCtD
Flurbiprofen—Retinal haemorrhage—Carmustine—malignant glioma	0.00434	0.0324	CcSEcCtD
Flurbiprofen—Meningitis—Carmustine—malignant glioma	0.00365	0.0273	CcSEcCtD
Flurbiprofen—Cerebral ischaemia—Temozolomide—malignant glioma	0.00283	0.0211	CcSEcCtD
Flurbiprofen—Myasthenia—Carmustine—malignant glioma	0.00225	0.0168	CcSEcCtD
Flurbiprofen—Parosmia—Temozolomide—malignant glioma	0.00211	0.0157	CcSEcCtD
Flurbiprofen—Lung disorder—Temozolomide—malignant glioma	0.00193	0.0144	CcSEcCtD
Flurbiprofen—Herpes zoster—Temozolomide—malignant glioma	0.00181	0.0136	CcSEcCtD
Flurbiprofen—Petechiae—Temozolomide—malignant glioma	0.00166	0.0124	CcSEcCtD
Flurbiprofen—Speech disorder—Carmustine—malignant glioma	0.00164	0.0123	CcSEcCtD
Flurbiprofen—Speech disorder—Temozolomide—malignant glioma	0.00159	0.0119	CcSEcCtD
Flurbiprofen—Breast pain—Temozolomide—malignant glioma	0.00157	0.0117	CcSEcCtD
Flurbiprofen—Drug interaction—Carmustine—malignant glioma	0.00152	0.0114	CcSEcCtD
Flurbiprofen—Leukocytosis—Carmustine—malignant glioma	0.0015	0.0112	CcSEcCtD
Flurbiprofen—Herpes simplex—Temozolomide—malignant glioma	0.00148	0.0111	CcSEcCtD
Flurbiprofen—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00144	0.0108	CcSEcCtD
Flurbiprofen—Hearing impaired—Temozolomide—malignant glioma	0.00143	0.0107	CcSEcCtD
Flurbiprofen—Pulmonary embolism—Carmustine—malignant glioma	0.00141	0.0106	CcSEcCtD
Flurbiprofen—Pulmonary embolism—Temozolomide—malignant glioma	0.00137	0.0102	CcSEcCtD
Flurbiprofen—Vaginal inflammation—Temozolomide—malignant glioma	0.00137	0.0102	CcSEcCtD
Flurbiprofen—Skin exfoliation—Carmustine—malignant glioma	0.00135	0.0101	CcSEcCtD
Flurbiprofen—Skin exfoliation—Temozolomide—malignant glioma	0.0013	0.00975	CcSEcCtD
Flurbiprofen—Coma—Carmustine—malignant glioma	0.00129	0.00966	CcSEcCtD
Flurbiprofen—Vaginal infection—Temozolomide—malignant glioma	0.00129	0.00964	CcSEcCtD
Flurbiprofen—Aplastic anaemia—Temozolomide—malignant glioma	0.00128	0.00959	CcSEcCtD
Flurbiprofen—Sepsis—Carmustine—malignant glioma	0.00123	0.00917	CcSEcCtD
Flurbiprofen—Phlebitis—Carmustine—malignant glioma	0.00119	0.0089	CcSEcCtD
Flurbiprofen—Gastroenteritis—Temozolomide—malignant glioma	0.00112	0.00836	CcSEcCtD
Flurbiprofen—Deafness—Temozolomide—malignant glioma	0.00111	0.00829	CcSEcCtD
Flurbiprofen—Vascular purpura—Temozolomide—malignant glioma	0.00111	0.00829	CcSEcCtD
Flurbiprofen—Hepatic failure—Temozolomide—malignant glioma	0.0011	0.00825	CcSEcCtD
Flurbiprofen—Amnesia—Carmustine—malignant glioma	0.00109	0.00816	CcSEcCtD
Flurbiprofen—Amnesia—Temozolomide—malignant glioma	0.00106	0.00789	CcSEcCtD
Flurbiprofen—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00105	0.00786	CcSEcCtD
Flurbiprofen—Thirst—Temozolomide—malignant glioma	0.00104	0.00779	CcSEcCtD
Flurbiprofen—Purpura—Temozolomide—malignant glioma	0.00103	0.00769	CcSEcCtD
Flurbiprofen—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00103	0.00767	CcSEcCtD
Flurbiprofen—Diplopia—Carmustine—malignant glioma	0.00103	0.00767	CcSEcCtD
Flurbiprofen—Diplopia—Temozolomide—malignant glioma	0.000991	0.00741	CcSEcCtD
Flurbiprofen—Affect lability—Temozolomide—malignant glioma	0.000976	0.0073	CcSEcCtD
Flurbiprofen—Ataxia—Carmustine—malignant glioma	0.000965	0.00721	CcSEcCtD
Flurbiprofen—Mood swings—Temozolomide—malignant glioma	0.000939	0.00702	CcSEcCtD
Flurbiprofen—Ataxia—Temozolomide—malignant glioma	0.000932	0.00697	CcSEcCtD
Flurbiprofen—Dry skin—Temozolomide—malignant glioma	0.000909	0.0068	CcSEcCtD
Flurbiprofen—Muscular weakness—Carmustine—malignant glioma	0.000905	0.00677	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000893	0.00668	CcSEcCtD
Flurbiprofen—Muscular weakness—Temozolomide—malignant glioma	0.000874	0.00654	CcSEcCtD
Flurbiprofen—Abdominal distension—Temozolomide—malignant glioma	0.000863	0.00645	CcSEcCtD
Flurbiprofen—Pancytopenia—Carmustine—malignant glioma	0.000842	0.0063	CcSEcCtD
Flurbiprofen—Neutropenia—Carmustine—malignant glioma	0.000829	0.0062	CcSEcCtD
Flurbiprofen—Bronchitis—Temozolomide—malignant glioma	0.000824	0.00616	CcSEcCtD
Flurbiprofen—Pancytopenia—Temozolomide—malignant glioma	0.000814	0.00608	CcSEcCtD
Flurbiprofen—Dysuria—Temozolomide—malignant glioma	0.000801	0.00599	CcSEcCtD
Flurbiprofen—Neutropenia—Temozolomide—malignant glioma	0.000801	0.00599	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Carmustine—malignant glioma	0.0008	0.00598	CcSEcCtD
Flurbiprofen—Pneumonia—Carmustine—malignant glioma	0.000795	0.00595	CcSEcCtD
Flurbiprofen—Erectile dysfunction—Temozolomide—malignant glioma	0.000789	0.0059	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Temozolomide—malignant glioma	0.000782	0.00585	CcSEcCtD
Flurbiprofen—Renal failure—Carmustine—malignant glioma	0.000777	0.00581	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Temozolomide—malignant glioma	0.000773	0.00578	CcSEcCtD
Flurbiprofen—Stomatitis—Carmustine—malignant glioma	0.000771	0.00576	CcSEcCtD
Flurbiprofen—Urinary tract infection—Carmustine—malignant glioma	0.000769	0.00575	CcSEcCtD
Flurbiprofen—Pneumonia—Temozolomide—malignant glioma	0.000769	0.00575	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000758	0.00566	CcSEcCtD
Flurbiprofen—Stomatitis—Temozolomide—malignant glioma	0.000745	0.00557	CcSEcCtD
Flurbiprofen—Urinary tract infection—Temozolomide—malignant glioma	0.000743	0.00555	CcSEcCtD
Flurbiprofen—Sinusitis—Temozolomide—malignant glioma	0.000717	0.00536	CcSEcCtD
Flurbiprofen—Haemoglobin—Carmustine—malignant glioma	0.000713	0.00533	CcSEcCtD
Flurbiprofen—Haemorrhage—Carmustine—malignant glioma	0.00071	0.00531	CcSEcCtD
Flurbiprofen—Hallucination—Carmustine—malignant glioma	0.000706	0.00528	CcSEcCtD
Flurbiprofen—Haemoglobin—Temozolomide—malignant glioma	0.000689	0.00515	CcSEcCtD
Flurbiprofen—Haemorrhage—Temozolomide—malignant glioma	0.000686	0.00513	CcSEcCtD
Flurbiprofen—Hepatitis—Temozolomide—malignant glioma	0.000686	0.00513	CcSEcCtD
Flurbiprofen—Visual impairment—Carmustine—malignant glioma	0.000684	0.00511	CcSEcCtD
Flurbiprofen—Hallucination—Temozolomide—malignant glioma	0.000682	0.0051	CcSEcCtD
Flurbiprofen—Pharyngitis—Temozolomide—malignant glioma	0.000681	0.00509	CcSEcCtD
Flurbiprofen—Visual impairment—Temozolomide—malignant glioma	0.000661	0.00494	CcSEcCtD
Flurbiprofen—Erythema multiforme—Temozolomide—malignant glioma	0.000649	0.00485	CcSEcCtD
Flurbiprofen—Tinnitus—Temozolomide—malignant glioma	0.00064	0.00478	CcSEcCtD
Flurbiprofen—Carprofen—PTGS1—malignant glioma	0.000637	0.0628	CrCbGaD
Flurbiprofen—Arrhythmia—Carmustine—malignant glioma	0.000634	0.00474	CcSEcCtD
Flurbiprofen—Alopecia—Carmustine—malignant glioma	0.000627	0.00469	CcSEcCtD
Flurbiprofen—Angiopathy—Temozolomide—malignant glioma	0.000622	0.00465	CcSEcCtD
Flurbiprofen—Chills—Temozolomide—malignant glioma	0.000615	0.0046	CcSEcCtD
Flurbiprofen—Alopecia—Temozolomide—malignant glioma	0.000606	0.00453	CcSEcCtD
Flurbiprofen—Tremor—Carmustine—malignant glioma	0.000579	0.00433	CcSEcCtD
Flurbiprofen—Anaemia—Carmustine—malignant glioma	0.000571	0.00427	CcSEcCtD
Flurbiprofen—Tremor—Temozolomide—malignant glioma	0.000559	0.00418	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Temozolomide—malignant glioma	0.000554	0.00414	CcSEcCtD
Flurbiprofen—Leukopenia—Carmustine—malignant glioma	0.000553	0.00414	CcSEcCtD
Flurbiprofen—Anaemia—Temozolomide—malignant glioma	0.000552	0.00413	CcSEcCtD
Flurbiprofen—Angioedema—Temozolomide—malignant glioma	0.000546	0.00408	CcSEcCtD
Flurbiprofen—Malaise—Temozolomide—malignant glioma	0.000538	0.00403	CcSEcCtD
Flurbiprofen—Vertigo—Temozolomide—malignant glioma	0.000536	0.00401	CcSEcCtD
Flurbiprofen—Convulsion—Carmustine—malignant glioma	0.000535	0.004	CcSEcCtD
Flurbiprofen—Leukopenia—Temozolomide—malignant glioma	0.000534	0.004	CcSEcCtD
Flurbiprofen—Hypertension—Carmustine—malignant glioma	0.000533	0.00399	CcSEcCtD
Flurbiprofen—Warfarin—CYP2C18—malignant glioma	0.000531	0.0523	CrCbGaD
Flurbiprofen—Palpitations—Temozolomide—malignant glioma	0.000528	0.00395	CcSEcCtD
Flurbiprofen—Myalgia—Carmustine—malignant glioma	0.000526	0.00393	CcSEcCtD
Flurbiprofen—Anxiety—Carmustine—malignant glioma	0.000524	0.00392	CcSEcCtD
Flurbiprofen—Cough—Temozolomide—malignant glioma	0.000521	0.0039	CcSEcCtD
Flurbiprofen—Tiaprofenic acid—PTGS1—malignant glioma	0.000519	0.0512	CrCbGaD
Flurbiprofen—Convulsion—Temozolomide—malignant glioma	0.000517	0.00387	CcSEcCtD
Flurbiprofen—Hypertension—Temozolomide—malignant glioma	0.000516	0.00385	CcSEcCtD
Flurbiprofen—Confusional state—Carmustine—malignant glioma	0.000508	0.0038	CcSEcCtD
Flurbiprofen—Myalgia—Temozolomide—malignant glioma	0.000508	0.0038	CcSEcCtD
Flurbiprofen—Anxiety—Temozolomide—malignant glioma	0.000507	0.00379	CcSEcCtD
Flurbiprofen—Oedema—Carmustine—malignant glioma	0.000504	0.00377	CcSEcCtD
Flurbiprofen—Discomfort—Temozolomide—malignant glioma	0.000502	0.00376	CcSEcCtD
Flurbiprofen—Infection—Carmustine—malignant glioma	0.000501	0.00375	CcSEcCtD
Flurbiprofen—Dry mouth—Temozolomide—malignant glioma	0.000497	0.00372	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Carmustine—malignant glioma	0.000494	0.00369	CcSEcCtD
Flurbiprofen—Tachycardia—Carmustine—malignant glioma	0.000492	0.00368	CcSEcCtD
Flurbiprofen—Confusional state—Temozolomide—malignant glioma	0.000491	0.00367	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Temozolomide—malignant glioma	0.000487	0.00364	CcSEcCtD
Flurbiprofen—Oedema—Temozolomide—malignant glioma	0.000487	0.00364	CcSEcCtD
Flurbiprofen—Infection—Temozolomide—malignant glioma	0.000484	0.00362	CcSEcCtD
Flurbiprofen—Ibuprofen—BCL2—malignant glioma	0.000482	0.0474	CrCbGaD
Flurbiprofen—Anorexia—Carmustine—malignant glioma	0.000481	0.00359	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Temozolomide—malignant glioma	0.000477	0.00357	CcSEcCtD
Flurbiprofen—Fenbufen—PTGS1—malignant glioma	0.000472	0.0465	CrCbGaD
Flurbiprofen—Hypotension—Carmustine—malignant glioma	0.000471	0.00352	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Temozolomide—malignant glioma	0.000471	0.00352	CcSEcCtD
Flurbiprofen—Anorexia—Temozolomide—malignant glioma	0.000465	0.00347	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000459	0.00344	CcSEcCtD
Flurbiprofen—Insomnia—Carmustine—malignant glioma	0.000456	0.00341	CcSEcCtD
Flurbiprofen—Diflunisal—PTGS1—malignant glioma	0.000454	0.0447	CrCbGaD
Flurbiprofen—Paraesthesia—Carmustine—malignant glioma	0.000453	0.00339	CcSEcCtD
Flurbiprofen—Dyspnoea—Carmustine—malignant glioma	0.00045	0.00336	CcSEcCtD
Flurbiprofen—Somnolence—Carmustine—malignant glioma	0.000448	0.00335	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000444	0.00332	CcSEcCtD
Flurbiprofen—Insomnia—Temozolomide—malignant glioma	0.000441	0.0033	CcSEcCtD
Flurbiprofen—Decreased appetite—Carmustine—malignant glioma	0.000438	0.00328	CcSEcCtD
Flurbiprofen—Paraesthesia—Temozolomide—malignant glioma	0.000438	0.00327	CcSEcCtD
Flurbiprofen—Dyspnoea—Temozolomide—malignant glioma	0.000434	0.00325	CcSEcCtD
Flurbiprofen—Somnolence—Temozolomide—malignant glioma	0.000433	0.00324	CcSEcCtD
Flurbiprofen—Constipation—Carmustine—malignant glioma	0.000431	0.00322	CcSEcCtD
Flurbiprofen—Pain—Carmustine—malignant glioma	0.000431	0.00322	CcSEcCtD
Flurbiprofen—Dyspepsia—Temozolomide—malignant glioma	0.000429	0.00321	CcSEcCtD
Flurbiprofen—Decreased appetite—Temozolomide—malignant glioma	0.000424	0.00317	CcSEcCtD
Flurbiprofen—Pain—Temozolomide—malignant glioma	0.000417	0.00312	CcSEcCtD
Flurbiprofen—Constipation—Temozolomide—malignant glioma	0.000417	0.00312	CcSEcCtD
Flurbiprofen—Feeling abnormal—Carmustine—malignant glioma	0.000416	0.00311	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Carmustine—malignant glioma	0.000412	0.00308	CcSEcCtD
Flurbiprofen—Oxaprozin—PTGS1—malignant glioma	0.00041	0.0404	CrCbGaD
Flurbiprofen—Salsalate—PTGS1—malignant glioma	0.00041	0.0404	CrCbGaD
Flurbiprofen—Feeling abnormal—Temozolomide—malignant glioma	0.000402	0.003	CcSEcCtD
Flurbiprofen—Abdominal pain—Carmustine—malignant glioma	0.000399	0.00298	CcSEcCtD
Flurbiprofen—Body temperature increased—Carmustine—malignant glioma	0.000399	0.00298	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Temozolomide—malignant glioma	0.000398	0.00298	CcSEcCtD
Flurbiprofen—Suprofen—PTGS1—malignant glioma	0.000393	0.0388	CrCbGaD
Flurbiprofen—Ketoprofen—CXCL8—malignant glioma	0.000392	0.0387	CrCbGaD
Flurbiprofen—Urticaria—Temozolomide—malignant glioma	0.000387	0.00289	CcSEcCtD
Flurbiprofen—Ibuprofen—CXCL8—malignant glioma	0.000386	0.038	CrCbGaD
Flurbiprofen—Body temperature increased—Temozolomide—malignant glioma	0.000385	0.00288	CcSEcCtD
Flurbiprofen—Abdominal pain—Temozolomide—malignant glioma	0.000385	0.00288	CcSEcCtD
Flurbiprofen—Hypersensitivity—Carmustine—malignant glioma	0.000372	0.00278	CcSEcCtD
Flurbiprofen—Carprofen—PTGS2—malignant glioma	0.000364	0.0359	CrCbGaD
Flurbiprofen—Asthenia—Carmustine—malignant glioma	0.000362	0.00271	CcSEcCtD
Flurbiprofen—Hypersensitivity—Temozolomide—malignant glioma	0.000359	0.00268	CcSEcCtD
Flurbiprofen—Asthenia—Temozolomide—malignant glioma	0.00035	0.00261	CcSEcCtD
Flurbiprofen—Diarrhoea—Carmustine—malignant glioma	0.000345	0.00258	CcSEcCtD
Flurbiprofen—Pruritus—Temozolomide—malignant glioma	0.000345	0.00258	CcSEcCtD
Flurbiprofen—Fenoprofen—PTGS1—malignant glioma	0.000339	0.0334	CrCbGaD
Flurbiprofen—Dizziness—Carmustine—malignant glioma	0.000333	0.00249	CcSEcCtD
Flurbiprofen—Diarrhoea—Temozolomide—malignant glioma	0.000333	0.00249	CcSEcCtD
Flurbiprofen—Dizziness—Temozolomide—malignant glioma	0.000322	0.00241	CcSEcCtD
Flurbiprofen—Vomiting—Carmustine—malignant glioma	0.000321	0.0024	CcSEcCtD
Flurbiprofen—Rash—Carmustine—malignant glioma	0.000318	0.00238	CcSEcCtD
Flurbiprofen—Dermatitis—Carmustine—malignant glioma	0.000318	0.00238	CcSEcCtD
Flurbiprofen—Headache—Carmustine—malignant glioma	0.000316	0.00236	CcSEcCtD
Flurbiprofen—Mefenamic acid—PTGS1—malignant glioma	0.000315	0.031	CrCbGaD
Flurbiprofen—Vomiting—Temozolomide—malignant glioma	0.00031	0.00232	CcSEcCtD
Flurbiprofen—Naproxen—PTGS1—malignant glioma	0.000309	0.0304	CrCbGaD
Flurbiprofen—Rash—Temozolomide—malignant glioma	0.000307	0.0023	CcSEcCtD
Flurbiprofen—Dermatitis—Temozolomide—malignant glioma	0.000307	0.0023	CcSEcCtD
Flurbiprofen—Headache—Temozolomide—malignant glioma	0.000305	0.00228	CcSEcCtD
Flurbiprofen—Nausea—Carmustine—malignant glioma	0.0003	0.00224	CcSEcCtD
Flurbiprofen—Tiaprofenic acid—PTGS2—malignant glioma	0.000297	0.0292	CrCbGaD
Flurbiprofen—Nausea—Temozolomide—malignant glioma	0.000289	0.00216	CcSEcCtD
Flurbiprofen—Fenbufen—PTGS2—malignant glioma	0.00027	0.0266	CrCbGaD
Flurbiprofen—Ibuprofen—PPARG—malignant glioma	0.000267	0.0263	CrCbGaD
Flurbiprofen—Diflunisal—PTGS2—malignant glioma	0.000259	0.0256	CrCbGaD
Flurbiprofen—Diazepam—CYP2C18—malignant glioma	0.000247	0.0243	CrCbGaD
Flurbiprofen—Oxaprozin—PTGS2—malignant glioma	0.000235	0.0231	CrCbGaD
Flurbiprofen—Salsalate—PTGS2—malignant glioma	0.000235	0.0231	CrCbGaD
Flurbiprofen—Suprofen—PTGS2—malignant glioma	0.000225	0.0222	CrCbGaD
Flurbiprofen—Temazepam—CYP2B6—malignant glioma	0.000221	0.0217	CrCbGaD
Flurbiprofen—Ketoprofen—PTGS1—malignant glioma	0.0002	0.0197	CrCbGaD
Flurbiprofen—Ibuprofen—PTGS1—malignant glioma	0.000197	0.0194	CrCbGaD
Flurbiprofen—Fenoprofen—PTGS2—malignant glioma	0.000194	0.0191	CrCbGaD
Flurbiprofen—Diazepam—CYP2B6—malignant glioma	0.000183	0.0181	CrCbGaD
Flurbiprofen—Mefenamic acid—PTGS2—malignant glioma	0.00018	0.0177	CrCbGaD
Flurbiprofen—Naproxen—PTGS2—malignant glioma	0.000176	0.0174	CrCbGaD
Flurbiprofen—Diazepam—PTGS1—malignant glioma	0.000121	0.0119	CrCbGaD
Flurbiprofen—Ketoprofen—PTGS2—malignant glioma	0.000114	0.0113	CrCbGaD
Flurbiprofen—Ibuprofen—PTGS2—malignant glioma	0.000113	0.0111	CrCbGaD
Flurbiprofen—UGT1A9—Metabolism—PTGS1—malignant glioma	3.14e-05	0.000294	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTGS1—malignant glioma	3.14e-05	0.000294	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.12e-05	0.000293	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	3.11e-05	0.000292	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HIST1H3B—malignant glioma	3.11e-05	0.000291	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.1e-05	0.00029	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYP2B6—malignant glioma	3.09e-05	0.000289	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—NCOR1—malignant glioma	3.08e-05	0.000289	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—SOD1—malignant glioma	3.07e-05	0.000288	CbGpPWpGaD
Flurbiprofen—ABCC4—Transmembrane transport of small molecules—RAF1—malignant glioma	3.07e-05	0.000288	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.06e-05	0.000287	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	3.04e-05	0.000285	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.03e-05	0.000284	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.02e-05	0.000283	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.96e-05	0.000278	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—BCHE—malignant glioma	2.92e-05	0.000273	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—BCHE—malignant glioma	2.92e-05	0.000273	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.9e-05	0.000272	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—SLC5A5—malignant glioma	2.88e-05	0.00027	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—SLC5A5—malignant glioma	2.88e-05	0.00027	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—ASMT—malignant glioma	2.87e-05	0.000269	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—GSTP1—malignant glioma	2.85e-05	0.000268	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—JAG2—malignant glioma	2.84e-05	0.000266	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PTEN—malignant glioma	2.83e-05	0.000265	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—IDH1—malignant glioma	2.82e-05	0.000265	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.82e-05	0.000265	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PTK2—malignant glioma	2.82e-05	0.000264	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.81e-05	0.000263	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.8e-05	0.000262	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.8e-05	0.000262	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	2.79e-05	0.000262	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CAT—malignant glioma	2.78e-05	0.00026	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—SPHK1—malignant glioma	2.73e-05	0.000256	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTT1—malignant glioma	2.73e-05	0.000256	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.72e-05	0.000255	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—VEGFA—malignant glioma	2.7e-05	0.000253	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—BCAN—malignant glioma	2.7e-05	0.000253	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.7e-05	0.000253	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CYP2C18—malignant glioma	2.68e-05	0.000251	CbGpPWpGaD
Flurbiprofen—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	2.67e-05	0.00025	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—IDH2—malignant glioma	2.66e-05	0.000249	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—NCOR1—malignant glioma	2.62e-05	0.000246	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.57e-05	0.000241	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.55e-05	0.000239	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.52e-05	0.000237	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—CAV1—malignant glioma	2.51e-05	0.000236	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.51e-05	0.000235	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP2B6—malignant glioma	2.5e-05	0.000234	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.49e-05	0.000233	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—H3F3A—malignant glioma	2.4e-05	0.000225	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—BCHE—malignant glioma	2.38e-05	0.000223	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	2.37e-05	0.000222	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PDGFB—malignant glioma	2.37e-05	0.000222	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.35e-05	0.000221	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—SLC5A5—malignant glioma	2.35e-05	0.00022	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—GSTP1—malignant glioma	2.32e-05	0.000217	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—GSTP1—malignant glioma	2.32e-05	0.000217	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.3e-05	0.000216	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—KRAS—malignant glioma	2.3e-05	0.000215	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CG—malignant glioma	2.29e-05	0.000215	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—IDH1—malignant glioma	2.29e-05	0.000214	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—JAG1—malignant glioma	2.26e-05	0.000212	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CAT—malignant glioma	2.26e-05	0.000212	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CAT—malignant glioma	2.26e-05	0.000212	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—CAV1—malignant glioma	2.24e-05	0.00021	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.22e-05	0.000208	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.22e-05	0.000208	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FBXW7—malignant glioma	2.22e-05	0.000208	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—SPHK1—malignant glioma	2.21e-05	0.000207	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PPARG—malignant glioma	2.21e-05	0.000207	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.2e-05	0.000206	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—IDH2—malignant glioma	2.18e-05	0.000204	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CYP2C18—malignant glioma	2.17e-05	0.000203	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTT1—malignant glioma	2.17e-05	0.000203	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—CAV1—malignant glioma	2.14e-05	0.0002	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—F2—malignant glioma	2.14e-05	0.0002	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—FN1—malignant glioma	2.14e-05	0.0002	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—NCOR1—malignant glioma	2.13e-05	0.0002	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—NCOR1—malignant glioma	2.13e-05	0.0002	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—PIK3CA—malignant glioma	2.11e-05	0.000198	CbGpPWpGaD
Flurbiprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.1e-05	0.000197	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.05e-05	0.000192	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.05e-05	0.000192	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CG—malignant glioma	2.04e-05	0.000192	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.04e-05	0.000191	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—TP53—malignant glioma	2.04e-05	0.000191	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PTGS1—malignant glioma	2.03e-05	0.00019	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.02e-05	0.000189	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—EGF—malignant glioma	2.02e-05	0.000189	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CD—malignant glioma	2.01e-05	0.000189	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PTPN11—malignant glioma	2.01e-05	0.000188	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—PIK3CA—malignant glioma	2e-05	0.000187	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CG—malignant glioma	1.95e-05	0.000183	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.92e-05	0.00018	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—GSTP1—malignant glioma	1.89e-05	0.000177	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—BCHE—malignant glioma	1.89e-05	0.000177	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PPARG—malignant glioma	1.88e-05	0.000176	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—IDH1—malignant glioma	1.87e-05	0.000175	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—AKT2—malignant glioma	1.87e-05	0.000175	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—SLC5A5—malignant glioma	1.86e-05	0.000175	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.86e-05	0.000174	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.85e-05	0.000174	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CAT—malignant glioma	1.84e-05	0.000172	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—SPHK1—malignant glioma	1.81e-05	0.00017	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CD—malignant glioma	1.8e-05	0.000168	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.8e-05	0.000168	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.77e-05	0.000166	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.76e-05	0.000165	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CB—malignant glioma	1.76e-05	0.000165	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTT1—malignant glioma	1.75e-05	0.000164	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PTGS2—malignant glioma	1.74e-05	0.000163	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—CAV1—malignant glioma	1.74e-05	0.000163	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—NCOR1—malignant glioma	1.74e-05	0.000163	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—CAV1—malignant glioma	1.74e-05	0.000163	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CDKN2B—malignant glioma	1.74e-05	0.000163	CbGpPWpGaD
Flurbiprofen—ABCC4—Hemostasis—AKT1—malignant glioma	1.72e-05	0.000162	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CD—malignant glioma	1.71e-05	0.00016	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.67e-05	0.000157	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.66e-05	0.000156	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HES1—malignant glioma	1.66e-05	0.000155	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NCOR1—malignant glioma	1.65e-05	0.000154	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTGS1—malignant glioma	1.64e-05	0.000154	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.64e-05	0.000153	CbGpPWpGaD
Flurbiprofen—UGT2B4—Metabolism—AKT1—malignant glioma	1.63e-05	0.000153	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—RAF1—malignant glioma	1.6e-05	0.00015	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CG—malignant glioma	1.58e-05	0.000148	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CG—malignant glioma	1.58e-05	0.000148	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PDGFRA—malignant glioma	1.58e-05	0.000148	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CB—malignant glioma	1.57e-05	0.000147	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PPARG—malignant glioma	1.53e-05	0.000143	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PPARG—malignant glioma	1.53e-05	0.000143	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—BCHE—malignant glioma	1.53e-05	0.000143	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.52e-05	0.000143	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.52e-05	0.000143	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PTEN—malignant glioma	1.52e-05	0.000142	CbGpPWpGaD
Flurbiprofen—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1.51e-05	0.000142	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—SLC5A5—malignant glioma	1.51e-05	0.000141	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—GSTP1—malignant glioma	1.5e-05	0.000141	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CB—malignant glioma	1.49e-05	0.00014	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PTGS2—malignant glioma	1.48e-05	0.000139	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.47e-05	0.000138	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CAT—malignant glioma	1.46e-05	0.000137	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—TERT—malignant glioma	1.45e-05	0.000136	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HLA-A—malignant glioma	1.45e-05	0.000136	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—IL2—malignant glioma	1.44e-05	0.000135	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTT1—malignant glioma	1.43e-05	0.000134	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.43e-05	0.000134	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PDGFB—malignant glioma	1.42e-05	0.000133	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—CAV1—malignant glioma	1.42e-05	0.000133	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.41e-05	0.000132	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FGFR1—malignant glioma	1.41e-05	0.000132	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CD—malignant glioma	1.39e-05	0.00013	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CD—malignant glioma	1.39e-05	0.00013	CbGpPWpGaD
Flurbiprofen—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	1.39e-05	0.00013	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—HIF1A—malignant glioma	1.39e-05	0.00013	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—NCOR1—malignant glioma	1.38e-05	0.000129	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.35e-05	0.000127	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTGS1—malignant glioma	1.34e-05	0.000126	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CAV1—malignant glioma	1.34e-05	0.000126	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.34e-05	0.000125	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CG—malignant glioma	1.29e-05	0.000121	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PTEN—malignant glioma	1.29e-05	0.000121	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—BAD—malignant glioma	1.26e-05	0.000118	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—NOTCH1—malignant glioma	1.25e-05	0.000117	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—BCHE—malignant glioma	1.25e-05	0.000117	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PPARG—malignant glioma	1.25e-05	0.000117	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.23e-05	0.000116	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.23e-05	0.000115	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—CD80—malignant glioma	1.23e-05	0.000115	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—APC—malignant glioma	1.22e-05	0.000115	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—VEGFA—malignant glioma	1.22e-05	0.000115	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—GSTP1—malignant glioma	1.21e-05	0.000114	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CB—malignant glioma	1.21e-05	0.000114	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CB—malignant glioma	1.21e-05	0.000114	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EGF—malignant glioma	1.21e-05	0.000113	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTGS2—malignant glioma	1.2e-05	0.000113	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTGS2—malignant glioma	1.2e-05	0.000113	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PTPN11—malignant glioma	1.2e-05	0.000113	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CAT—malignant glioma	1.18e-05	0.000111	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.17e-05	0.000109	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.16e-05	0.000108	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—BRAF—malignant glioma	1.15e-05	0.000108	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CD—malignant glioma	1.13e-05	0.000106	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—CAV1—malignant glioma	1.12e-05	0.000105	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—AKT2—malignant glioma	1.12e-05	0.000105	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—NCOR1—malignant glioma	1.12e-05	0.000105	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CD—malignant glioma	1.08e-05	0.000101	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.07e-05	0.000101	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—PIK3CA—malignant glioma	1.07e-05	0.0001	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PTEN—malignant glioma	1.05e-05	9.82e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PTEN—malignant glioma	1.05e-05	9.82e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—KRAS—malignant glioma	1.04e-05	9.74e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—FGF2—malignant glioma	1.03e-05	9.65e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CG—malignant glioma	1.02e-05	9.6e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.01e-05	9.45e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—GSTP1—malignant glioma	9.94e-06	9.32e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CB—malignant glioma	9.89e-06	9.27e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PPARG—malignant glioma	9.89e-06	9.27e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PTGS2—malignant glioma	9.8e-06	9.18e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CAT—malignant glioma	9.67e-06	9.07e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MDM2—malignant glioma	9.63e-06	9.03e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—RAF1—malignant glioma	9.6e-06	9e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—PIK3CA—malignant glioma	9.55e-06	8.95e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—ERBB2—malignant glioma	9.5e-06	8.9e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CB—malignant glioma	9.37e-06	8.78e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—TP53—malignant glioma	9.24e-06	8.66e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—NCOR1—malignant glioma	9.13e-06	8.56e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—PIK3CA—malignant glioma	9.1e-06	8.53e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—CAV1—malignant glioma	9.1e-06	8.53e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CD—malignant glioma	9e-06	8.44e-05	CbGpPWpGaD
Flurbiprofen—UGT1A3—Metabolism—AKT1—malignant glioma	8.74e-06	8.19e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.69e-06	8.15e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PTEN—malignant glioma	8.54e-06	8.01e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CG—malignant glioma	8.29e-06	7.77e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PTEN—malignant glioma	8.1e-06	7.59e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PPARG—malignant glioma	8e-06	7.5e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CB—malignant glioma	7.85e-06	7.36e-05	CbGpPWpGaD
Flurbiprofen—ALB—Hemostasis—AKT1—malignant glioma	7.8e-06	7.31e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—CAV1—malignant glioma	7.45e-06	6.98e-05	CbGpPWpGaD
Flurbiprofen—UGT2B7—Metabolism—AKT1—malignant glioma	7.43e-06	6.97e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—PIK3CA—malignant glioma	7.39e-06	6.93e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—PIK3CA—malignant glioma	7.39e-06	6.93e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CD—malignant glioma	7.28e-06	6.83e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—STAT3—malignant glioma	7.24e-06	6.79e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.11e-06	6.67e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CG—malignant glioma	6.78e-06	6.36e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PTEN—malignant glioma	6.78e-06	6.36e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—MYC—malignant glioma	6.73e-06	6.31e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—EGFR—malignant glioma	6.58e-06	6.17e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PPARG—malignant glioma	6.55e-06	6.14e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CB—malignant glioma	6.35e-06	5.95e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTGS2—malignant glioma	6.29e-06	5.9e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—KRAS—malignant glioma	6.22e-06	5.83e-05	CbGpPWpGaD
Flurbiprofen—UGT1A1—Metabolism—AKT1—malignant glioma	6.04e-06	5.66e-05	CbGpPWpGaD
Flurbiprofen—UGT1A9—Metabolism—AKT1—malignant glioma	6.04e-06	5.66e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—PIK3CA—malignant glioma	6.03e-06	5.65e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.96e-06	5.59e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—PIK3CA—malignant glioma	5.71e-06	5.35e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PTEN—malignant glioma	5.49e-06	5.14e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.2e-06	4.87e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTGS2—malignant glioma	5.15e-06	4.83e-05	CbGpPWpGaD
Flurbiprofen—PTGS1—Metabolism—AKT1—malignant glioma	4.92e-06	4.61e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—PIK3CA—malignant glioma	4.78e-06	4.48e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Disease—AKT1—malignant glioma	4.67e-06	4.37e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PTEN—malignant glioma	4.49e-06	4.21e-05	CbGpPWpGaD
Flurbiprofen—PTGS2—Metabolism—AKT1—malignant glioma	3.91e-06	3.66e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—PIK3CA—malignant glioma	3.87e-06	3.63e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.17e-06	2.97e-05	CbGpPWpGaD
Flurbiprofen—ALB—Metabolism—AKT1—malignant glioma	3.16e-06	2.96e-05	CbGpPWpGaD
Flurbiprofen—CYP2C9—Metabolism—AKT1—malignant glioma	2.59e-06	2.43e-05	CbGpPWpGaD
